Stéphane Piat Presents Carmat at LSI USA ‘23

CARMAT develops and commercializes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Stéphane Piat
Stéphane Piat
CEO, Carmat